Bristol, Merck checkpoint inhibitors focus of FDA advisory committee meeting
An FDA advisory panel on Bristol Myers Squibb Opdivo and Merck Keytruda will examine if PD-L1 tumor expression should limit ...
dvm36011h
New vaccine protects against feline leukemia virus
The technological innovation is an expansion of the NOBIVAC NXT platform, and a breakthrough achievement against one of the ...
Pharmaceutical Technology1d
Merck gets grant for genetic markers for clostridium difficile treatment response
Discover Merck's groundbreaking patent on genetic markers linked to enhanced C. difficile treatment responses. Learn how personalized therapy can improve patient outcomes.
3rd Circuit Revives Fosamax MDL Over Questions of Preemption
The decision, which the U.S. Court of Appeals for the Third Circuit said was a close call, hinged on whether an informal ...
Common diabetic drug Metformin may become a wonder drug to keep people young; Study finds promising results in monkeys
A recent study has shown that metformin, a diabetes medication, may slow ageing in monkeys by preserving cognitive function ...
The Lancet2d
The respiratory syncytial virus vaccine and monoclonal antibody landscape: the road to global access
UMC Utrecht (LJB and NIM) received grants from AbbVie, AstraZeneca, The Bill & Melinda Gates Foundation, the Dutch Lung Foundation, The Gates Medical Research Institute, GlaxoSmithKline (GSK), Janssen ...
Pfizer Advances On Its Cancer Journey
Pfizer Inc (NYSE: PFE) presented positive trial data for experimental drug designed for patients suffering from cancer ...
Merck Receives Positive EU CHMP Opinions for KEYTRUDA® (pembrolizumab) Regimens as Treatment for Patients With Two Types of Gynecologic Cancers
Positive opinion granted for KEYTRUDA plus chemotherapy for the first-line treatment of adult patients with primary advanced or recurrent endometrial carcinoma who are candidates for systemic therapy, ...
Summit Therapeutics Bests Merck's Top Selling Drug In Phase III Trial
Summit Therapeutics' ivonescimab poised for FDA approval, with the potential to disrupt the oncology market. Read more on ...
Korean Biotech’s Shares Quadruple In Seven Months, Becomes Kosdaq’s Biggest Stock
Alteogen overtakes EcoPro BM, South Korea’s largest producer of cathodes for EV batteries, to become the biggest company on the Kosdaq by market capitalization.
The microRNA Blood Test That Might Outsmart Alzheimer’s
Recent research highlights the potential of microRNAs as cost-effective and less invasive biomarkers for early diagnosis and ...
Investor's Business Daily on MSN8d
Merck Scores Two Key Victories With Keytruda In Women's Cancers
Merck's Keytruda scored two important victories in women's cancer, according to presentations Sunday at the ESMO meeting.